Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @DrJLi
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @DrJLi
-
Jonathan Li proslijedio/la je Tweet
Disappointing, to say the least, but there were concerns that the marginal efficacy observed in the RV144 trial that this was based on was not going to be reproducible. Important result nonetheless, kudos to all who worked on it and participated.https://twitter.com/NIAIDNews/status/1224318047785107458 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jonathan Li proslijedio/la je Tweet
An assembly of some of the more interesting
#2019nCoV links from the past week; am sure there are some I missed. S/O@RosenthalHealth@IsaacATFlorence@maiamajumder@sciencecohen@DrJLi@trvrb@LennyMBernstein@k_stephensonMD, et al. Latest post:https://blogs.jwatch.org/hiv-id-observations/index.php/a-coronavirus-id-link-o-rama-because-im-not-watching-the-super-bowl/2020/02/02/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lancet report of 41 cases of the novel
#coronavirus (https://bit.ly/38DAGHL ) refers to ongoing randomized trial of lopinavir/r+IFN vs placebo, registered Jan 23: http://www.chictr.org.cn/showprojen.aspx?proj=48684 …. It's open-label, N=80/arm, not on O2, but sat <=94%, outcome is clinical improvement at 28dHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jonathan Li proslijedio/la je Tweet
@maunankshah1 and colleagues#HIV-ASSIST to the test and found that#antiretroviral recommendations for#HIVtreatment were consistent with those of expert#HIVCareProvidershttps://twitter.com/JournalGIM/status/1204838536266092546 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jonathan Li proslijedio/la je Tweet
The November issue of O-F-I-D was a winner, with the electronic table of contents summarized in this link. The cover is also terrific, featuring the early 20th century poster genius Leonetto Cappiello!
@IDSAInfo@OUPAcademic@maunankshah1@DrJLi@jobadd https://academic.oup.com/ofid/issue/6/11 pic.twitter.com/h0YG0S3VPY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jonathan Li proslijedio/la je Tweet
It's
#WorldAIDSDay. There were approximately 37.9 million people living with#HIV at the end of 2018.
79% had been diagnosed
62% were receiving treatment
53% had achieved suppression of the HIV virus to the point at which they were at low risk of infecting others.pic.twitter.com/L6Zlv31Gnk
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What a great discussion by
@PaulSaxMD and will definitely be looking for the Sax sign the next time I’m on service! Lucky to count him as a friend and mentor at the@BrighamWomenshttps://twitter.com/CPSolvers/status/1197469706065592320 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jonathan Li proslijedio/la je Tweet
#MedTwitter, couldn't get enough of@PaulSaxMD's clinical reasoning? We've got you covered! Special guest@PaulSaxMD returns for a new clinical unknown presented by@EmmaHLevine!http://bit.ly/2rYLzE0Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As an HIV researcher, cases like this keep me up at night. It's an uphill fight against human nature as non-HIV researchers can attest to: https://bit.ly/34dzfhw . Agree that we should be offering
#PreP once logistics are worked out: funding, consent, monitoring of partner(s).https://twitter.com/defeatHIV/status/1197967811689107456 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jonathan Li proslijedio/la je Tweet
Proclaiming that you have a cure for HIV (or even advertising that you're only hopeful that you do) is more likely to generate clicks than publishing the gritty reality of
#HIV cure research.#HIVcure hype-atitis harms people living with HIV! http://bit.ly/2dVENE1#NotYetpic.twitter.com/eL1zBa2T2e
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great blog post by
@PaulSaxMD, including the hype about a company called AGT. They want to 1) enrich for HIV-specific T cells, 2) protect them from HIV somehow, 3) re-infuse into the pts. But details vague, there's no publications and no human studies yet. A case of hype>>factshttps://twitter.com/PaulSaxMD/status/1194092767418494978 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jonathan Li proslijedio/la je Tweet
Yesterday, Nov. 7, marked the 28th anniversary of my HIV announcement. I feel so blessed to be here and want to thank everyone for their support, prayers, and well wishes over these years!
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Videos now available from a fantastic
@HarvardCFAR symposium on#hivcure organized with@RMKGandhi, featuring talks by Bob Siliciano,@k_stephensonMD, Boris Juelg, Gaurav Gaiha, Susana Valente, Jim Riley, and Xu Yu.https://www.youtube.com/playlist?list=PLDfiSpPkOkM5DdtZQ0w01EtEErkrWAT4P …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Provocative analysis by
@JudithCurrier of the Promise study showing a far higher frequency of women with delayed viral rebound after stopping ART compared to a mostly male@ACTGNetwork study. But most Promise participants were African: could it also be race and HIV clade-driven?https://twitter.com/CarlosdelRio7/status/1191900102081822720 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jonathan Li proslijedio/la je Tweet
Hey! Next week is this nice
@HarvardCFAR symposium that I helped organize (with@RMKGandhi and friends), so register if you can attend! I'll be talking about therapeutic#HIV vaccines, and we've got bNAbs on the agenda too! https://tinyurl.com/y2nk3epe pic.twitter.com/Fh2hCsihl1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A well-written review discussing the pros/cons of ART for HIV spontaneous controllers. ACTG A5308 and other studies show benefit for viremic controllers, but still controversial for those with largely undetectable viral loads and high CD4s.https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(19)30264-4/fulltext …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
So proud of my team and their work with
@RMKGandhi and the@ACTGNetwork! There is not a more dedicated group of people working on HIV resistance, reservoirs and an#hivcurehttps://twitter.com/AIDS_Journal/status/1183701365308178432 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.